PT  - JOURNAL ARTICLE
AU  - Xu, Yongchao
AU  - Ma, Liya
AU  - Yang, Fan
AU  - Chen, Yanyan
AU  - Ma, Ke
AU  - Yang, Jiehua
AU  - Yang, Xian
AU  - Chen, Yaobing
AU  - Shu, Chang
AU  - Fan, Ziwei
AU  - Gan, Jiefeng
AU  - Zou, Xinyu
AU  - Huang, Renhao
AU  - Zhang, Changzheng
AU  - Liu, Xiaowu
AU  - Tu, Dandan
AU  - Xu, Chuou
AU  - Zhang, Wenqing
AU  - Yang, Dehua
AU  - Wang, Ming-Wei
AU  - Wang, Xi
AU  - Xie, Xiaoliang
AU  - Leng, Hongxiang
AU  - Holalkere, Nagaraj
AU  - Halin, Neil J.
AU  - Kamel, Ihab Roushdy
AU  - Wu, Jia
AU  - Peng, Xuehua
AU  - Wang, Xiang
AU  - Shao, Jianbo
AU  - Mongkolwat, Pattanasak
AU  - Zhang, Jianjun
AU  - Rubin, Daniel L.
AU  - Wang, Guoping
AU  - Zheng, Chuangsheng
AU  - Li, Zhen
AU  - Bai, Xiang
AU  - Xia, Tian
TI  - A collaborative online AI engine for CT-based COVID-19 diagnosis
AID  - 10.1101/2020.05.10.20096073
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.10.20096073
4099  - http://medrxiv.org/content/early/2020/05/19/2020.05.10.20096073.short
4100  - http://medrxiv.org/content/early/2020/05/19/2020.05.10.20096073.full
AB  - Artificial intelligence can potentially provide a substantial role in streamlining chest computed tomography (CT) diagnosis of COVID-19 patients. However, several critical hurdles have impeded the development of robust AI model, which include deficiency, isolation, and heterogeneity of CT data generated from diverse institutions. These bring about lack of generalization of AI model and therefore prevent it from applications in clinical practices. To overcome this, we proposed a federated learning-based Unified CT-COVID AI Diagnostic Initiative (UCADI, http://www.ai-ct-covid.team/), a decentralized architecture where the AI model is distributed to and executed at each host institution with the data sources or client ends for training and inferencing without sharing individual patient data. Specifically, we firstly developed an initial AI CT model based on data collected from three Tongji hospitals in Wuhan. After model evaluation, we found that the initial model can identify COVID from Tongji CT test data at near radiologist-level (97.5% sensitivity) but performed worse when it was tested on COVID cases from Wuhan Union Hospital (72% sensitivity), indicating a lack of model generalization. Next, we used the publicly available UCADI framework to build a federated model which integrated COVID CT cases from the Tongji hospitals and Wuhan Union hospital (WU) without transferring the WU data. The federated model not only performed similarly on Tongji test data but improved the detection sensitivity (98%) on WU test cases. The UCADI framework will allow participants worldwide to use and contribute to the model, to deliver a real-world, globally built and validated clinic CT-COVID AI tool. This effort directly supports the United Nations Sustainable Development Goals’ number 3, Good Health and Well-Being, and allows sharing and transferring of knowledge to fight this devastating disease around the world.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialno clinical trialFunding StatementThis study was supported by HUST COVID-19 Rapid Response Call (No. 2020kfyXGYJ031, No. 2020kfyXGYJ093, No. 2020kfyXGYJ094) and the National Natural Science Foundation of China (61703171 and 81771801). This work was also supported in part by a grant from the National Cancer Institute, National Institutes of Health, U01CA242879, and Thammasat University Research fund under the NRCT, Contract No. 25/2561, for the project of ‘Digital platform for sustainable digital economy development’, based on the RUN Digital Cluster collaboration scheme.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data used for developing the initial model and federated models during the current study are not publicly available. We claimed that this study was approved by the Ethics Committee Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology to access this dataset for our research purpose. http://www.ai-ct-covid.team/